-
CSR Summary Not Yet Available
-
NCT02471183
-
Primary Citation
-
Data Specification Not Available
You are not logged in.
Please login to continue selecting trials.
Trial Information
Generic NameSelexipagProduct NameUPTRAVI®Therapeutic AreaRespiratory Tract (Lung and Bronchial) DiseasesEnrollment34% Female82.4%% White82.4%
Product ClassProstacyclin receptor agonistSponsor Protocol NumberAC-065A304Data PartnerJohnson & JohnsonCondition StudiedHypertension, Pulmonary, ArterialMean/Median Age (Years)53.2
Supporting Documentation
- Collected Datasets Available
- Data Definition Specification Available
- Protocol with Amendments Available
- Statistical Analysis Plan Available
- Clinical Study Report Available